WeVote

Bill

Bill

SB 461

Generally revise administration of drug and substance laws

2025 Regular Session Introduced by Sara Novak

Montana's SB 461 sought to revise drug and substance administration laws but failed to advance past disagreement between legislative chambers on amendments.

(S) Died in Process
0
WeVote Research Nonpartisan
Bill Summary · SB 461

Legislative bill overview

SB 461 proposed general revisions to Montana's drug and substance administration laws. The bill advanced through the House Business and Labor Committee with amendments but ultimately died in the legislative process without reaching a final vote.

Why is this important

Drug policy administration affects criminal justice outcomes, public health responses, treatment access, and law enforcement priorities. Revisions to these laws can significantly impact sentencing guidelines, treatment options, and how Montana allocates resources for substance abuse prevention and rehabilitation.

Potential points of contention

  • The bill's specific amendments remain unclear from legislative records, making it difficult to identify exact areas of disagreement that led to its failure
  • Business and Labor Committee involvement suggests the bill may have addressed workplace drug testing, occupational health standards, or employer liability—areas where business and worker interests often conflict
  • The "Not Concurred" action on second reading indicates disagreement between chambers on the amended version, suggesting partisan or policy divisions prevented consensus

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.